Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
  1. 4 Open-market sale See Remarks sold 3,228 shares at $13.45 ($43,417)
  2. 4 Planned sale See Remarks sold 9,375 shares at an average $16.03 ($150,260)
  3. 4 Open-market buy 10% owner bought 1,470,000 shares at $19.00 ($27,930,000)
  4. 4 Planned sale Director sold 42,000 shares at $15.00 ($630,000)
  5. 4 Planned sale Director sold 14,000 shares at an average $13.50 ($189,000)
  6. 4 Planned sale Director sold 93,445 shares at an average $14.65 ($1,369,324)
  7. 4 Planned sale Director sold 134,218 shares at an average $13.58 ($1,823,159)
  8. 4 Planned sale Director sold 20,000 shares at an average $13.47 ($269,461)
  9. 4 Planned sale See Remarks sold 441,031 shares at an average $14.57 ($6,427,085)
  10. 4 Planned sale Chief Financial Officer sold 260,036 shares at an average $15.78 ($4,103,979)
  11. 4 Planned sale Director sold 16,115 shares at an average $13.48 ($217,297)
  12. 4 Planned sale Director sold 16,115 shares at $6.79 ($109,421)
  13. 4 Open-market buy Director bought 1,000 shares at $6.69 ($6,688)
  14. 4 Planned sale Director sold 10,000 shares at $10.00 ($100,000)
  15. 4 Planned sale President and CEO sold 217,351 shares at $10.10 ($2,194,810)
  16. 4 Planned sale Director sold 21,000 shares at $9.25 ($194,250)
  17. 4 Grant or award Director acquired 12,700 shares (grant or award)
  18. 4 Grant or award Director acquired 12,700 shares (grant or award)
  19. 4 Grant or award Director acquired 25,400 shares (grant or award)
  20. 4 Grant or award Director acquired 12,700 shares (grant or award)

Page 2 of 14 · 274 filings